<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               CONTRAINDICATIONS<BR>               <BR>                  Protriptyline hydrochloride tablets are contraindicated in <BR>patients who have shown prior hypersensitivity to it.<BR>                  It should not be given concomitantly with a monoamine oxidase inhibiting <BR>compound. Hyperpyretic crises, severe convulsions, and deaths have occurred in <BR>patients receiving tricyclic antidepressant and monoamine oxidase inhibiting <BR>drugs simultaneously. When it is desired to substitute protriptyline for a <BR>monoamine oxidase inhibitor, a minimum of 14 days should be allowed to elapse <BR>after the latter is discontinued. Protriptyline should then be initiated <BR>cautiously with gradual increase in dosage until optimum response is <BR>achieved.<BR>                  Protriptyline is contraindicated in patients taking cisapride because of the <BR>possibility of adverse cardiac interactions including prolongation of the QT <BR>interval, cardiac arrhythmias and conduction system disturbances.<BR>                  This drug should not be used during the acute recovery phase following <BR>myocardial infarction.<BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>